Report Detail
Global Pneumococcal Vaccine Market Insights, Forecast to 2025
- RnM2652569 |
- 05 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
The global Pneumococcal Vaccine market is valued at 7140 million US$ in 2018 and will reach 1263900 million US$ by the end of 2025, growing at a CAGR of 91.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Pneumococcal Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccine in these regions.
This research report categorizes the global Pneumococcal Vaccine market by top players/brands, region, type and end user. This report also studies the global Pneumococcal Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Market size by Product
PPSV 23
PCV 7/13
PCV 10
Market size by End User
Child
Adult
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pneumococcal Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pneumococcal Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pneumococcal Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pneumococcal Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pneumococcal Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pneumococcal Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pneumococcal Vaccine Market Size Growth Rate by Product
- 1.4.2 PPSV 23
- 1.4.3 PCV 7/13
- 1.4.4 PCV 10
- 1.5 Market by End User
- 1.5.1 Global Pneumococcal Vaccine Market Size Growth Rate by End User
- 1.5.2 Child
- 1.5.3 Adult
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pneumococcal Vaccine Market Size
- 2.1.1 Global Pneumococcal Vaccine Revenue 2014-2025
- 2.1.2 Global Pneumococcal Vaccine Sales 2014-2025
- 2.2 Pneumococcal Vaccine Growth Rate by Regions
- 2.2.1 Global Pneumococcal Vaccine Sales by Regions
- 2.2.2 Global Pneumococcal Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pneumococcal Vaccine Sales by Manufacturers
- 3.1.1 Pneumococcal Vaccine Sales by Manufacturers
- 3.1.2 Pneumococcal Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Pneumococcal Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Pneumococcal Vaccine Revenue by Manufacturers
- 3.2.1 Pneumococcal Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Pneumococcal Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Pneumococcal Vaccine Price by Manufacturers
- 3.4 Pneumococcal Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pneumococcal Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Pneumococcal Vaccine Sales by Product
- 4.2 Global Pneumococcal Vaccine Revenue by Product
- 4.3 Pneumococcal Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Pneumococcal Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Pneumococcal Vaccine by Countries
- 6.1.1 North America Pneumococcal Vaccine Sales by Countries
- 6.1.2 North America Pneumococcal Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pneumococcal Vaccine by Product
- 6.3 North America Pneumococcal Vaccine by End User
7 Europe
- 7.1 Europe Pneumococcal Vaccine by Countries
- 7.1.1 Europe Pneumococcal Vaccine Sales by Countries
- 7.1.2 Europe Pneumococcal Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pneumococcal Vaccine by Product
- 7.3 Europe Pneumococcal Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Pneumococcal Vaccine by Countries
- 8.1.1 Asia Pacific Pneumococcal Vaccine Sales by Countries
- 8.1.2 Asia Pacific Pneumococcal Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Pneumococcal Vaccine by Product
- 8.3 Asia Pacific Pneumococcal Vaccine by End User
9 Central & South America
- 9.1 Central & South America Pneumococcal Vaccine by Countries
- 9.1.1 Central & South America Pneumococcal Vaccine Sales by Countries
- 9.1.2 Central & South America Pneumococcal Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Pneumococcal Vaccine by Product
- 9.3 Central & South America Pneumococcal Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Pneumococcal Vaccine by Countries
- 10.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pneumococcal Vaccine by Product
- 10.3 Middle East and Africa Pneumococcal Vaccine by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Pneumococcal Vaccine Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Pneumococcal Vaccine Products Offered
- 11.2.5 GSK Recent Development
- 11.3 MSD
- 11.3.1 MSD Company Details
- 11.3.2 Company Business Overview
- 11.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 MSD Pneumococcal Vaccine Products Offered
- 11.3.5 MSD Recent Development
- 11.4 Sanofipasteur
- 11.4.1 Sanofipasteur Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered
- 11.4.5 Sanofipasteur Recent Development
- 11.5 CDIBP
- 11.5.1 CDIBP Company Details
- 11.5.2 Company Business Overview
- 11.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 CDIBP Pneumococcal Vaccine Products Offered
- 11.5.5 CDIBP Recent Development
12 Future Forecast
- 12.1 Pneumococcal Vaccine Market Forecast by Regions
- 12.1.1 Global Pneumococcal Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pneumococcal Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Pneumococcal Vaccine Market Forecast by Product
- 12.2.1 Global Pneumococcal Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Pneumococcal Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Pneumococcal Vaccine Market Forecast by End User
- 12.4 North America Pneumococcal Vaccine Forecast
- 12.5 Europe Pneumococcal Vaccine Forecast
- 12.6 Asia Pacific Pneumococcal Vaccine Forecast
- 12.7 Central & South America Pneumococcal Vaccine Forecast
- 12.8 Middle East and Africa Pneumococcal Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pneumococcal Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pneumococcal Vaccine . Industry analysis & Market Report on Pneumococcal Vaccine is a syndicated market report, published as Global Pneumococcal Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pneumococcal Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
